SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘10-Q’ for 6/30/18 – ‘EX-10.2’

On:  Friday, 8/10/18, at 4:35pm ET   ·   For:  6/30/18   ·   Accession #:  1615774-18-7848   ·   File #:  1-35527

Previous ‘10-Q’:  ‘10-Q’ on 5/14/18 for 3/31/18   ·   Next:  ‘10-Q’ on 2/14/19 for 12/31/18   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/10/18  Emmaus Life Sciences, Inc.        10-Q        6/30/18   60:4.5M                                   S2 Filings LLC/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    453K 
 2: EX-10.2     Material Contract                                   HTML     18K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
12: R1          Document and Entity Information                     HTML     44K 
13: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    123K 
14: R3          Condensed Consolidated Balance Sheets               HTML     46K 
                (Parenthetical)                                                  
15: R4          Unaudited Condensed Consolidated Statements of      HTML     75K 
                Operations                                                       
16: R5          Unaudited Condensed Consolidated Statements of      HTML    109K 
                Cash Flows                                                       
17: R6          Organization, Nature of Operations and Going        HTML     30K 
                Concern Uncertainty                                              
18: R7          Summary of Significant Accounting Policies          HTML     85K 
19: R8          Accounts Receivable                                 HTML     24K 
20: R9          Long - Term Borrowings and Other Note Payables      HTML     23K 
21: R10         Acquisition                                         HTML     55K 
22: R11         Stockholders'Equity                                 HTML    159K 
23: R12         Convertible Preferred Stock                         HTML     35K 
24: R13         Income Taxes                                        HTML     26K 
25: R14         Related Party Transactions                          HTML     24K 
26: R15         Loss Per Share                                      HTML     45K 
27: R16         Commitments and Contingent Liabilities              HTML     32K 
28: R17         Summary of Significant Accounting Policies          HTML    155K 
                (Policies)                                                       
29: R18         Summary of Significant Accounting Policies          HTML     30K 
                (Tables)                                                         
30: R19         Accounts Receivable (Tables)                        HTML     23K 
31: R20         Acquisition (Tables)                                HTML     49K 
32: R21         Stockholders' Equity (Tables)                       HTML    117K 
33: R22         Loss Per Share (Tables)                             HTML     44K 
34: R23         Commitments and Contingent Liabilities (Tables)     HTML     26K 
35: R24         Organization, Nature of Operations and Going        HTML     30K 
                Concern Uncertainty (Details Narrative)                          
36: R25         Summary of Significant Accounting Policies          HTML     24K 
                (Details)                                                        
37: R26         Summary of Significant Accounting Policies          HTML     32K 
                (Details 1)                                                      
38: R27         Summary of Significant Accounting Policies          HTML     68K 
                (Details Narrative)                                              
39: R28         Accounts Receivable (Details)                       HTML     26K 
40: R29         Long - Term Borrowings and Other Note Payables      HTML     48K 
                (Details Narrative)                                              
41: R30         Acquisition (Details)                               HTML     64K 
42: R31         Acquisition (Details 1)                             HTML     27K 
43: R32         Acquisition (Details Narrative)                     HTML     55K 
44: R33         Stockholders' Equity (Details)                      HTML     31K 
45: R34         Stockholders' Equity (Details 1)                    HTML     24K 
46: R35         Stockholders' Equity (Details 2)                    HTML     52K 
47: R36         Stockholders' Equity (Details 3)                    HTML     38K 
48: R37         Stockholders' Equity (Details 4)                    HTML     31K 
49: R38         Stockholders' Equity (Details 5)                    HTML     53K 
50: R39         Stockholders' Equity (Details Narrative)            HTML    225K 
51: R40         Stockholders' Equity (Details Narrative 1)          HTML     40K 
52: R41         Convertible Preferred Stock (Details Narrative)     HTML     54K 
53: R42         Income Taxes (Details Narrative)                    HTML     37K 
54: R43         Related Party Transactions (Details Narrative)      HTML     33K 
55: R44         Loss Per Share (Details)                            HTML     39K 
56: R45         Commitments and Contingent Liabilities (Details)    HTML     22K 
57: R46         Commitments and Contingent Liabilities (Details     HTML     37K 
                Narrative)                                                       
59: XML         IDEA XML File -- Filing Summary                      XML    105K 
58: EXCEL       IDEA Workbook of Financial Reports                  XLSX     82K 
 6: EX-101.INS  XBRL Instance -- mynd-20180630                       XML   1.29M 
 8: EX-101.CAL  XBRL Calculations -- mynd-20180630_cal               XML    156K 
 9: EX-101.DEF  XBRL Definitions -- mynd-20180630_def                XML    562K 
10: EX-101.LAB  XBRL Labels -- mynd-20180630_lab                     XML    903K 
11: EX-101.PRE  XBRL Presentations -- mynd-20180630_pre              XML    733K 
 7: EX-101.SCH  XBRL Schema -- mynd-20180630                         XSD    132K 
60: ZIP         XBRL Zipped Folder -- 0001615774-18-007848-xbrl      Zip    139K 


‘EX-10.2’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 10.2

 

AGREEMENT

 

This Agreement (“Agreement”) is made by and between MYnd Analytics, Inc. (hereinafter “MYnd” or “Company”) and George C. Carpenter, IV (hereinafter “Employee”) dated as of May 25, 2018.

 

Between March 1, 2015 and July 31, 2015, the Employee agreed to defer his salary in the amount of $9,250.00 per month for a total of $101,500.00. The Employee hereby agrees to receive 11,205 shares of common restricted stock under the Company’s Amended and Restated 2012 Omnibus Incentive Compensation Plan (the “2012 Plan” ); which is granted and vest immediately upon the date of this Agreement to reduce the amount owe by the Company by $25,437.50 (25% of the outstanding amount). The outstanding amount as of the date of this Agreement of deferred salary is $76,062.50.

 

The Parties hereby agree that this Agreement resolves any outstanding defer salary or wages, as to the 25% listed above only, that the Employee might be owed by the Company under California Labor Code, including Section 200 et seq., relating to salary, commission, compensation, benefits and other matters.

 

Agreed and Accepted:

 

Employee

 

By:/s/ George C. Carpenter, IV

George C. Carpenter, IV

MYnd Analytics, Inc.

 

By:/s/ Don D’Ambrosio

Don D’Ambrosio, CFO

 

 C: 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/10/18
For Period end:6/30/18
5/25/184
7/31/15
3/1/15
 List all Filings 
Top
Filing Submission 0001615774-18-007848   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 9:56:39.1pm ET